亚洲有码中文字幕_啊啊啊在线视频_婷婷五月天成人高清无码_91美女操逼_亚洲AV成人片无码精品花岛_思思操思思热思思干SM_男女网站免费观看_成人精品97久久_欧美激情精品久久久久久变态_操逼视频免费无码_天堂久久网_激情88色色色_亚洲性爱视频在线播放_超碰在线干_成人激情av

北京索萊寶科技

專注于生物學(xué)試劑及試劑盒領(lǐng)域

服務(wù)熱線:18101056239

產(chǎn)品中心

PRODUCTS CENTER

當(dāng)前位置:首頁產(chǎn)品中心抗體Polyclonal AntibodyK106513PAnti-VCAM-1 Polyclonal Antibody

Anti-VCAM-1 Polyclonal Antibody
產(chǎn)品簡介:

Anti-VCAM-1 Polyclonal Antibody
應(yīng)用 WB IHC
稀釋比例WB 1:2000-5000.IHC 1:50-200.
交叉反應(yīng)Human Mouse Rat

產(chǎn)品型號(hào):K106513P

更新時(shí)間:2022-08-15

廠商性質(zhì):生產(chǎn)廠家

訪 問 量 :924

服務(wù)熱線

010-50973130

立即咨詢
產(chǎn)品介紹

Anti-VCAM-1 Polyclonal Antibody

英文名稱Anti-VCAM-1 Polyclonal Antibody
宿主Rabbit
別名INCAM-100;CD106;CUL 5;Cullin5;CUL5_HUMAN
應(yīng)用WB IHC
稀釋比例WB 1:2000-5000.IHC 1:50-200.
交叉反應(yīng)Human Mouse Rat
蛋白分子量81kDa
Gene ID7412
保存Store at -20°C. Avoid freeze / thaw cycles.
儲(chǔ)存液Buffer: PBS with 0.03% Proclin300, 50% glycerol, pH7.3.
純化方法Affinity purification
亞型IgG
免疫原A synthetic peptide of human VCAM-1
性狀液體
Public Immunogen RangeA synthetic peptide of human VCAM-1
Subcellular LocationsCytoplasm Nucleus Cell membrane
Swiss ProtP19320
克隆類型Polyclonal Antibody
背景資料VCAM1 is important in cell-cell recognition. Appears to function in leukocyte-endothelial cell adhesion. Interacts with the integrins alpha4 beta1 (beta 1 integrin VLA4) and alpha4 beta7 on leukocytes, and mediates both adhesion and signal transduction. The VCAM1/VLA4 interaction may play a pathophysiologic role both in immune responses and in leukocyte emigration to sites of inflammation. VCAM1 is also expressed by several non endothelial cell types including some macrophages, follicular dendritic cells and bone marrow, stromal cells.

在線留言

ONLINE MESSAGE

留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說明:

  • 驗(yàn)證碼:

    請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
  • 服務(wù)熱線 010-50973130
  • 電子郵箱

    3193328036@qq.com

掃碼加微信

Copyright © 2025 北京索萊寶科技有限公司版權(quán)所有    備案號(hào):

技術(shù)支持:化工儀器網(wǎng)    sitemap.xml

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |